MKI67 and neoplasm: Further, staining of cytospin sections from the disaggregated and pooled tumors (n = 4), with the proliferation marker Ki-67, showed a markedly reduced number of Ki-67 expressing cells, after the combined treatment, with the JNJ-40346527 and cisplatin exhibiting weak activity when administered as single agents to the tumor bearing mice (Figure 4C).